This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Innovations by Premal Patel in Cancer Treatment
Introduction
Premal Patel is an accomplished inventor based in South San Francisco, CA (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Patel's work focuses on the development of effective combinations of AKT inhibitor compounds and chemotherapeutic agents.
Latest Patents
Patel's latest patents include groundbreaking inventions that provide combinations of AKT inhibitor compounds and chemotherapeutic agents. These inventions are particularly useful for treating hyperproliferative disorders, such as cancer. The combinations comprise a compound of formula I or a pharmaceutically acceptable salt thereof, along with one or more agents selected from a list that includes 5-FU, a platinum agent, leucovorin, irinotecan, docetaxel, doxorubicin, gemcitabine, SN-38, capecitabine, temozolomide, paclitaxel, bevacizumab, pertuzumab, tamoxifen, rapamycin, and lapatinib.
Career Highlights
Premal Patel is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to focus on advancing cancer therapies and improving patient outcomes.
Collaborations
Throughout his career, Patel has collaborated with notable colleagues, including Michelle Nannini and Deepak Sampath. These collaborations have contributed to the success of his research and the development of his patents.
Conclusion
Premal Patel's contributions to cancer treatment through his innovative patents highlight his dedication to improving healthcare. His work at Genentech, along with his collaborations, continues to pave the way for advancements in the field.